Raltegravir and Atazanavir Replacing Current Suppressive Treatment Because of Side Effects in Current Treatment
NCT00751153
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
40
Enrollment
OTHER
Sponsor class
Conditions
HIV Infections
Interventions
DRUG:
Raltegravir and Atazanavir
Sponsor
Peter J. Ruane, M.D., Inc.